Skip to main content
SpringerLink
Log in

Sekundärneoplasien

Nach erfolgreicher Krebsbehandlung bei Kindern und Jugendlichen

  • Topic
  • Published:
best practice onkologie Aims and scope

Die Therapie von Krebserkrankungen bei Kindern und Jugendlichen hat in den vergangenen 5 Jahrzehnten erhebliche Fortschritte gemacht. Lag die 5-Jahres-Überlebensrate in den 1960er-Jahren nur bei etwa 5–10%, so stieg diese bis heute auf mehr als 75% [7, 20].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6

Literatur

  1. Bhatia S et al (2002) Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983. Blood 99:4257–4264

    Article  CAS  PubMed  Google Scholar 

  2. Bhatia S et al (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin’s disease: report from the Late Effects Study Group. J Clin Oncol 23:4386–4394

    Article  Google Scholar 

  3. Bhatia S, Meadows AT (2006) Long-term follow-up of childhood cancer survivors: future directions for clinical care and research. Pediatr Blood Cancer 46:143–148

    Article  PubMed  Google Scholar 

  4. Bölling T, Schuck A, Pape H et al (2007) Register for the evaluation of side effects after radiation in childhood and adolescence-first results. Klin Padiatr 219:139–145

    Article  PubMed  Google Scholar 

  5. Dörffel W et al (2015) Secondary malignancies following treatment for Hodgkin’s lymphoma in childhood and adolescence — a cohort study with more than 30 years’ follow-up. Dtsch Arztebl Int 112(18):320–327; DOI: 10.3238/arztebl.2015.0320

    PubMed  PubMed Central  Google Scholar 

  6. Frey E et al (2009) Nachsorge im Erwachsenenalter. Monatsschr Kinderheilkd 157:339–345

    Article  Google Scholar 

  7. Gadner H, Gaedicke G, Niemeyer C, Ritter J (2006) Pädiatrische Hämatologie und Onkologie. Springer, Berlin Heidelberg

    Book  Google Scholar 

  8. Haupt R, Spinetta JJ, Ban I et al (2007) Long term survivors of childhood cancer: Cure and care. Eur J Cancer 43(12):1778–1780

    Article  PubMed  Google Scholar 

  9. Kaatsch P, Spix J (2006) German childhood cancer registry — annual report 2005 (1980-2004). (Jahresbericht 2005 [1980–2004] des Deutschen Kinderkrebsregisters). www.kinderkrebsregister.de. Institut für Medizinische Biometrie, Epidemiologie und Informatik, Universität Mainz

  10. Klein G et al (2003) Second malignant neoplasms after treatment of childhood cancer. Eur J Cancer 39:808–817

    Article  CAS  PubMed  Google Scholar 

  11. Landier W, Bhatia S, Eshelman DA et al (2004) Development of risk-based guidelines for pediatric cancer survivors: the Children’s Oncology Group long-term follow-up guidelines from the Children’s Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22:4979–4990

    Article  PubMed  Google Scholar 

  12. Li Faumeni JF et al (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358–5362

    Google Scholar 

  13. Löning L et al (2000) Secondary neoplasms subsequent to Berlin-Frankfurt-Münster therapy of acute lymphoblastic leukemia in childhood: significantly lower risk without cranial radiotherapy. Blood 95:2770–2775

    PubMed  Google Scholar 

  14. Mertens AC et al (2001) Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol 19:3163–3172

    CAS  PubMed  Google Scholar 

  15. Moller TR et al (2001) Decreasing late mortality among five-year survivors of cancer in childhood and adolescence. A population-based study in the Nordic countries. J Clin Oncol 19:3173–3181

    CAS  PubMed  Google Scholar 

  16. Neglia JP et al (2001) Second malignant neoplasms in five-year survivors of childhood cancer: Childhood Cancer Survivor Study. J Natl Cancer Inst 93:618–629

    Article  CAS  PubMed  Google Scholar 

  17. Pui C-H et al (1991) Acute myeloid leukemia in children treated with epipodophyllotoxins for actue lymphoblastic leukaemia. N Engl J Med 325:1682–1687

    Article  CAS  PubMed  Google Scholar 

  18. Ritter J, Oehme J (1978) Akute myeloische Leukämie 11 Jahre nach erfolgreicher Therapie eines Morbus Hodgkin. Med Klin 73:1360–1362

    CAS  PubMed  Google Scholar 

  19. Ritter J, Ernst J (2015) Organbezogene Spätfolgen bei Kindern und Jugendlichen nach erfolgreicher Krebstherapie. Best Pract Oncol 10:21–28

    Article  Google Scholar 

  20. Roessig C, Juergens H, Schrappe M et al (2013) Effective childhood cancer treatment: The impact of larger scale clinical trials in Germany and Austria. Pediatr Blood Cancer 60:1574–1581

    Article  Google Scholar 

  21. Schellong G, Riepenhausen M, Ritter J et al (1997) Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin’s disease. J Clin Oncol 15:2247–53

    CAS  PubMed  Google Scholar 

  22. Schellong G, Riepenhausen M, Ehlert K Brämswig J, Dörffel W (2014) Brustkrebs bei jungen Frauen nach Therapie eines Hodgkin-Lymphoms im Kindes- und Jugendalter. Dtsch Arztebl Int 111(1–2):3–9; DOI: 10.3238/arztebl.2014.0003

    PubMed  PubMed Central  Google Scholar 

  23. Tucker MA et al (1991) Therapeutic radiation at a young age is linked to secondary thyroid cancer. J Natl Cancer Inst 96:261–268

    Google Scholar 

  24. Simone RV (2001) Late mortality in childhood cancer. J Clin Oncol 19:3161–3169

    CAS  PubMed  Google Scholar 

  25. Brown MC, Levitt GA, Frey et al; PanCareSurFup Consortium (2014) The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors. Pediatr Blood Cancer: 2014 Nov 8. doi: 10.1002/pbc.25310. [Epub ahead of print]. Zugegriffen: 19. Feb. 2016

  26. Bhatia S, Ramsay NK, Steinbuch M et al (1996) Malignant neoplasms following bone marrow transplantation. Blood: 87(9):3633–3639

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Münster, 48129, Münster, Deutschland

    J. Ritter (Pädiatrische Hämatologie und Onkologie)

Authors
  1. J. Ritter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Ritter.

Additional information

Einhaltung ethischer Richtlinien

Interessenkonflikt: Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ritter, J. Sekundärneoplasien. best practice onkologie 11, 8–16 (2016). https://doi.org/10.1007/s11654-016-0579-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11654-016-0579-0

Search

Navigation